Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
Bayer AG, Pharma Research Centre, Institute for Chemotherapy, Wuppertal, Germany.
A
A
Dalhoff
D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000493:pharmacokinetics / Q000494:pharmacology*; D024841:Fluoroquinolones; D008826:Microbial Sensitivity Tests; D015363:Quinolones / Q000493:pharmacokinetics / Q000494:pharmacology*; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D002939:Ciprofloxacin; C061363:sparfloxacin